Back

Evaluating the clinical utility of proBNP in patients with heart failure and low ejection fraction

30 August 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Systolic ventricular dysfunction Systolic Ventricular Dysfunction ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Efekan Dogramaci

Istanbul University Cerrahpasa, Istanbul (Turkiye)

3 More presentations in this session

Presentation thumbnail
The gut microbiota metabolite phenylacetic acid regulates cardiac senescence through phenylacetylation modification of histones
Doctor Y. Xie (Xi'an, CN)
Abstract Slides Video
Presentation thumbnail
Myth and facts of the relation between ischemic cardiopaty and heart failure with preserved ejection fraction in Argentina: analysis of the ArFey-Preser registry
Doctor G. Cursack (Esperanza, AR)
Abstract Slides Video
Presentation thumbnail
Blood protein profile of left ventricular diastolic function
Doctor E. Eerola (Uppsala, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Systolic ventricular dysfunction

The Event

Event poster

ESC Congress 2025

30 August 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Identifying predictors of risk stratification in hospitalized heart failure patients
thumbnail
Congress Presentation
The predictive value of NTproBNP levels early post-discharge in patients with heart failure
thumbnail
Congress Presentation
NT-proBNP at day 4 of hospitalization: a single prognostic marker for prediction of both in-hospital and post-discharge outcomes in acute heart failure with reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources